SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against ITT Educational Services , Inc. and Certain Officers - ESI
ESI Group, Winner of the 3rd "Ambitions d’Entrepreneurs" Trophy
ESI Declares Quarterly Dividend
Aethlon Medical Discloses Expanded Access "Emergency Use" Pathway To Treat Ebola in the United States
BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa Trial of Embryonic Stem Cell-Derived OpRegen® for the Treatment of the Dry Form of Age-Related Macular Degeneration
Aethlon Medical Announces Presentation of Ebola Treatment Data This Friday, November 14th at the ASN Annual Meeting
Société Générale Q3 2014 Results
Whether it's working his farm or running a mutual fund, he takes a cautious approach to risk.